Samer Alkassis, MD, PhD, discusses how cathepsin protease expression may correlate with survival outcomes to trastuzumab deruxtecan in metastatic breast cancer.
Samer Alkassis, MD, PhD
Advertisement
Samer Alkassis, MD, PhD, Hematologist/Oncologist at UCLA Health.
Articles by Samer Alkassis, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
The OncFive: Top Oncology Articles for the Week of 7/12
2
FDA Grants Fast Track Designation to Pelareorep in Pretreated SCAC
3
Subcutaneous Pembrolizumab Faces Scrutiny Over Convenience and Cost for Patients With Cancer
4
CD33-Directed CAR T-Cell Therapies Elicit Complete Remissions in Relapsed/Refractory AML
5